Related Experiment Video
Updated: Sep 5, 2025
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
10.1K
Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
Sha Ma1, Liangcai Ding2, Mengdi Cai2
1Department of Cardiology, Jining First People's Hospital, Jining Medical University, Jining, Shandong 272000, China.
Disease Markers
|July 12, 2022
Summary
The R92H polymorphism in the lipoprotein-associated phospholipase A2 (Lp-PLA2) gene is associated with an increased risk of coronary heart disease (CHD). This finding contributes to understanding the genetic factors influencing CHD development.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Coronary heart disease (CHD) is a leading cause of mortality worldwide.
- Understanding the genetic underpinnings of CHD is crucial for risk stratification and prevention.
- Lipoprotein-associated phospholipase A2 (Lp-PLA2) is implicated in inflammatory processes relevant to atherosclerosis.
Purpose of the Study:
- To investigate the association between specific Lp-PLA2 gene polymorphisms and the risk of developing coronary heart disease (CHD).
- To explore the potential role of Lp-PLA2 gene variations in the molecular genetics of CHD.
- To analyze the interaction of these polymorphisms as potential risk factors for CHD.
Main Methods:
- Case-control study involving 283 CHD patients and 261 healthy controls.
- Polymerase chain reaction (PCR) and direct DNA sequencing were used to identify R92H, V279F, and A379V polymorphisms in the Lp-PLA2 gene.
- Statistical analysis was performed to compare genotype frequencies and assess linkage disequilibrium.
Main Results:
- A significant difference in the frequencies of the R92H polymorphism was observed between CHD patients and healthy controls (P < 0.05).
- No significant differences in the frequencies of V279F and A379V polymorphisms were found between the groups.
- Strong linkage disequilibrium was detected between the R92H and A379V polymorphisms.
Conclusions:
- The R92H polymorphism in the Lp-PLA2 gene may be a contributing factor to an increased risk of coronary heart disease.
- Further research is warranted to elucidate the precise mechanisms by which Lp-PLA2 gene variants influence CHD pathogenesis.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.9K
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.4K
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
01:05Single Nucleotide Polymorphisms-SNPs
15.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
01:26Coronary Artery Disease II: Pathophysiology
32
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32
01:30Coronary Artery Disease I: Introduction
53
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
01:30Coronary Artery Disease III: Clinical Manifestations
30
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
30
01:26Coronary Artery Disease IV: Preventive Measures
31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31